These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32739935)

  • 1. Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic and Immunohistochemical Analysis of 34 Resected Cases.
    Lee SM; Sung CO
    Am J Surg Pathol; 2020 Oct; 44(10):1308-1321. PubMed ID: 32739935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
    Sciarra A; Missiaglia E; Trimech M; Melloul E; Brouland JP; Sempoux C; La Rosa S
    Endocr Pathol; 2020 Mar; 31(1):84-93. PubMed ID: 31981075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma.
    Chen C; Wang L; Liu X; Zhang G; Zhao Y; Geng Z
    Int J Clin Exp Pathol; 2015; 8(7):8218-26. PubMed ID: 26339390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small tubular-type adenocarcinoma commonly accompanied with a syringomatous pattern.
    Pehlivanoglu B; Araya JC; Lawrence S; Roa JC; Balci S; Andersen JB; Rashid A; Hsing AW; Zhu B; Gao YT; Koshiol J; Adsay V
    Hum Pathol; 2024 Aug; 150():67-73. PubMed ID: 38972607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
    Yun SP; Shin N; Seo HI
    World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
    Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 14. Coexisting tubular adenoma with a neuroendocrine carcinoma of colon allowing early surgical intervention and implicating a shared stem cell origin.
    Soliman ML; Tiwari A; Zhao Q
    World J Gastroenterol; 2017 Feb; 23(6):1106-1112. PubMed ID: 28246485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF
    Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
    Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
    Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
    Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer.
    Mochidome N; Koga Y; Ohishi Y; Miyazaki T; Matsuda R; Yamada Y; Aishima S; Nakamura M; Oda Y
    Hum Pathol; 2021 Aug; 114():44-53. PubMed ID: 33989638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
    Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
    Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
    Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
    Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed adenoneuroendocrine carcinoma of the gallbladder, amphicrine type: Case report and review of literature.
    Zhang D; Li P; Szankasi P; Liao X
    Pathol Res Pract; 2020 Jul; 216(7):152997. PubMed ID: 32534704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.